Literature DB >> 29152677

ADHD and Anxiety: Clinical Significance and Treatment Implications.

Frederick W Reimherr1,2, Barrie K Marchant3, Thomas E Gift4, Tammy A Steans3.   

Abstract

In comparison to the DSM formulation of ADHD, we have proposed that ADHD in adults should be divided into Inattentive and Emotional Dysregulation Presentations. Under both systems, there is potential overlap with generalized anxiety disorder (GAD). We compared data from four distinct populations: ADHD clinical trials, GAD clinical trials, an ADHD clinic, and a forensic clinic. Approximately 25% of patients in each population had comorbid ADHD and anxiety. Comorbid subjects reported more childhood ADHD symptoms and higher scores on ADHD scales and were more likely to fit criteria for ADHD Emotional Dysregulation Presentation or DSM-IV combined type. Comorbid subjects did not drop out at a higher rate and showed significant drug-placebo differences on ADHD symptoms, including Emotional Dysregulation. Conversely, although symptoms of anxiety decreased, there was no drug-placebo difference in improvement.

Entities:  

Keywords:  ADHD; Anxiety; Emotional dysregulation; GAD; Treatment response; WRAADDS

Mesh:

Year:  2017        PMID: 29152677     DOI: 10.1007/s11920-017-0859-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  40 in total

1.  Twenty-four-week treatment with extended release methylphenidate improves emotional symptoms in adult ADHD.

Authors:  Michael Rösler; Wolfgang Retz; Roland Fischer; Claudia Ose; Barbara Alm; Jürgen Deckert; Alexandra Philipsen; Sabine Herpertz; Richard Ammer
Journal:  World J Biol Psychiatry       Date:  2010-08       Impact factor: 4.132

2.  Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHD.

Authors:  Reid J Robison; Frederick W Reimherr; Phillip D Gale; Barrie K Marchant; Erika D Williams; Poonam Soni; Corinne Halls; Robert E Strong
Journal:  Ann Clin Psychiatry       Date:  2010-05       Impact factor: 1.567

3.  Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders.

Authors:  Mariam Ter-Stepanian; Natalie Grizenko; Michael Zappitelli; Ridha Joober
Journal:  Can J Psychiatry       Date:  2010-05       Impact factor: 4.356

4.  Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Todd M Durell; Lenard A Adler; Dave W Williams; Ahmed Deldar; James J McGough; Paul E Glaser; Richard L Rubin; Teresa A Pigott; Elias H Sarkis; Bethany K Fox
Journal:  J Clin Psychopharmacol       Date:  2013-02       Impact factor: 3.153

5.  Personality Disorder in Adult Attention-Deficit/Hyperactivity Disorder: Attrition and Change During Long-term Treatment.

Authors:  Thomas E Gift; Frederick W Reimherr; Barrie K Marchant; Tammy A Steans; Paul H Wender
Journal:  J Nerv Ment Dis       Date:  2016-05       Impact factor: 2.254

6.  Internalizing and externalizing behavior in adult ADHD.

Authors:  Christian Jacob; Silke Gross-Lesch; Thomas Jans; Julia Geissler; Andreas Reif; Astrid Dempfle; Klaus-Peter Lesch
Journal:  Atten Defic Hyperact Disord       Date:  2014-02-21

7.  Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD.

Authors:  Eva Snircova; Veronika Marcincakova-Husarova; Igor Hrtanek; Tomas Kulhan; Igor Ondrejka; Gabriela Nosalova
Journal:  Pediatr Int       Date:  2016-02-03       Impact factor: 1.524

8.  Attention deficit hyperactivity disorder and comorbid disorders: issues of overlapping symptoms.

Authors:  S Milberger; J Biederman; S V Faraone; J Murphy; M T Tsuang
Journal:  Am J Psychiatry       Date:  1995-12       Impact factor: 18.112

9.  Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.

Authors:  Timothy E Wilens; Lenard A Adler; Margaret D Weiss; David Michelson; Janet L Ramsey; Rodney J Moore; Didier Renard; Kathleen T Brady; Paula T Trzepacz; Leslie M Schuh; Lisa M Ahrbecker; Louise R Levine
Journal:  Drug Alcohol Depend       Date:  2008-04-09       Impact factor: 4.492

10.  Validation of the adult ADHD investigator symptom rating scale (AISRS).

Authors:  Thomas J Spencer; Lenard A Adler; Keith E Saylor; Thomas E Brown; James A Holdnack; Kory J Schuh; Paula T Trzepacz; Douglas K Kelsey
Journal:  J Atten Disord       Date:  2009-09-30       Impact factor: 3.256

View more
  9 in total

Review 1.  ADHD and Anxiety Disorder Comorbidity in Children and Adults: Diagnostic and Therapeutic Challenges.

Authors:  Ahmet Koyuncu; Tuğba Ayan; Ezgi Ince Guliyev; Seda Erbilgin; Erdem Deveci
Journal:  Curr Psychiatry Rep       Date:  2022-01-25       Impact factor: 5.285

2.  Questionnaire-based computational screening of adult ADHD.

Authors:  Arthur Trognon; Manon Richard
Journal:  BMC Psychiatry       Date:  2022-06-15       Impact factor: 4.144

3.  Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder.

Authors:  Geon Ho Bahn; Young Sik Lee; Hanik K Yoo; Eui-Jung Kim; Subin Park; Doug Hyun Han; Minha Hong; Bongseog Kim; Soyoung Irene Lee; Soo Young Bhang; Seung Yup Lee; Jin Pyo Hong; Yoo-Sook Joung
Journal:  Soa Chongsonyon Chongsin Uihak       Date:  2020-01-01

4.  Binge eating disorder hidden behind a wall of anxiety disorders.

Authors:  Amy Pipe; Beth Patterson; Michael Van Ameringen
Journal:  J Psychiatry Neurosci       Date:  2021-03-05       Impact factor: 6.186

5.  The voltage-gated Ca2+ channel subunit α2δ-4 regulates locomotor behavior and sensorimotor gating in mice.

Authors:  Annette Klomp; Ryotaro Omichi; Yoichiro Iwasa; Richard J Smith; Yuriy M Usachev; Andrew F Russo; Nandakumar S Narayanan; Amy Lee
Journal:  PLoS One       Date:  2022-03-30       Impact factor: 3.752

6.  The Loudness Dependence of Auditory Evoked Potentials is associated with the Symptom Severity and Treatment in Boys with Attention Deficit Hyperactivity Disorder.

Authors:  Eun Jin Park; Young-Min Park; Seung-Hwan Lee; Bongseog Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-08-31       Impact factor: 3.731

7.  Emotional dysregulation as trans-nosographic psychopathological dimension in adulthood: A systematic review.

Authors:  Claudia Carmassi; Lorenzo Conti; Davide Gravina; Benedetta Nardi; Liliana Dell'Osso
Journal:  Front Psychiatry       Date:  2022-08-29       Impact factor: 5.435

8.  Correlation of attention deficit hyperactivity disorder with gut microbiota according to the dietary intake of Korean elementary school students.

Authors:  Tae-Hwan Jung; Hyo-Jeong Hwang; Kyoung-Sik Han
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

9.  Sex-Specific ADHD-like Behaviour, Altered Metabolic Functions, and Altered EEG Activity in Sialyltransferase ST3GAL5-Deficient Mice.

Authors:  Tatyana Strekalova; Ekaterina Veniaminova; Evgeniy Svirin; Ekaterina Kopeikina; Tatyana Veremeyko; Amanda W Y Yung; Andrey Proshin; Shawn Zheng Kai Tan; Sharafuddin Khairuddin; Lee Wei Lim; Klaus-Peter Lesch; Susanne Walitza; Daniel C Anthony; Eugene D Ponomarev
Journal:  Biomolecules       Date:  2021-11-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.